Tags |
|
|
Links |
|
|
Digg It - Lean Manufacturing and Kaizen
Kaizen is one of the most important concepts in lean manufacturing. The meani
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ng of the Japanese word “Kaizen” continuous improvement. When it comes to Jus
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
t In Time systems or lean manufacturing, the system must change continuously
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
in order to deliver the value to customers. For an example lean manufacturing
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
always wants to eliminate wastes from the system. Finding and eliminating wa
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
tes from the system continuously is a Kaizen activity.
Kaizen concepts are d
Kaizen concepts are d
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
ifferent to the traditional management concepts. For an example one of the mo
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
st important theories of traditional management principle is the Management b
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
y exception. The simple meaning of this is that if everything is going OK the
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
n there is no need to change the way the system operate. But when it comes to
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
lean manufacturing and kaizen, it challenges the existing systems and find ou
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
t ways in which the system can be improved. Another very important aspect of
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
kaizen is trust on organizational employees to come up with the improvements.
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
This helps the system in many ways. People who carryout the work knows about
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
the work they do best. Therefore they can come up with the ideas to improve
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
t. Less resistance in change is another factor which will help in implementin
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
g and maintaining the system.
In a workplace where kaizen is practiced small
In a workplace where kaizen is practiced small
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
improvements to the system is made continuously. This makes the system dynam
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ic. Changes bring high value to the system and are less costly. Employees are
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
generally motivated. Importantly these organizations can win the competition
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/22905/diggit-Lean-Manufacturing-and-Kaizen.html">Lean Manufacturing and Kaizen</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/22905/diggit-Lean-Manufacturing-and-Kaizen.html]Lean Manufacturing and Kaizen[/url]
Related Articles:
Which is Better Digital or Offset Printing?
Work at Home Jobs Vs Self Employment
Internet Marketing - Watch What You Step In
Bookmark it:
|